Global Lecanemab Injection Market Growth 2026-2032

June 2026 | 85 pages | ID: GF7F9FD82863EN
LP Information

Abstracts

The global Lecanemab Injection market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

Lecanemab injection is a monoclonal antibody designed for the treatment of Alzheimer's disease.By binding to tamyloid-beta plaques,lecanemab helps to promote their removal from the brain, potentially slowing the progression of cognitive decline associated with the disease.

United States market for Lecanemab Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Lecanemab Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Lecanemab Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Lecanemab Injection players cover Eisai, Biogen, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LP Information, Inc. (LPI) ' newest research report, the ?Lecanemab Injection Industry Forecast? looks at past sales and reviews total world Lecanemab Injection sales in 2025, providing a comprehensive analysis by region and market sector of projected Lecanemab Injection sales for 2026 through 2032. With Lecanemab Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Lecanemab Injection industry.

This Insight Report provides a comprehensive analysis of the global Lecanemab Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Lecanemab Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Lecanemab Injection market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Lecanemab Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Lecanemab Injection.

This report presents a comprehensive overview, market shares, and growth opportunities of Lecanemab Injection market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• 200mg per Vial
• 500mg per Vial

Segmentation by Application:

• Mild Dementia
• Mild Cognitive Impairment
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Eisai
• Biogen

Key Questions Addressed in this Report
What is the 10-year outlook for the global Lecanemab Injection market?
What factors are driving Lecanemab Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Lecanemab Injection market opportunities vary by end market size?
How does Lecanemab Injection break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Lecanemab Injection Annual Sales 2021-2032
  2.1.2 World Current & Future Analysis for Lecanemab Injection by Geographic Region, 2021, 2025 & 2032
  2.1.3 World Current & Future Analysis for Lecanemab Injection by Country/Region, 2021, 2025 & 2032
2.2 Lecanemab Injection Segment by Type
  2.2.1 200mg per Vial
  2.2.2 500mg per Vial
  2.2.3 Lecanemab Injection Sales by Type
    2.2.3.1 Global Lecanemab Injection Sales Market Share by Type (2021-2026)
    2.2.3.2 Global Lecanemab Injection Revenue and Market Share by Type (2021-2026)
    2.2.3.3 Global Lecanemab Injection Sale Price by Type (2021-2026)
2.3 Lecanemab Injection Segment by Application
  2.3.1 Mild Dementia
  2.3.2 Mild Cognitive Impairment
  2.3.3 Other
  2.3.4 Lecanemab Injection Sales by Application
    2.3.4.1 Global Lecanemab Injection Sale Market Share by Application (2021-2026)
    2.3.4.2 Global Lecanemab Injection Revenue and Market Share by Application (2021-2026)
    2.3.4.3 Global Lecanemab Injection Sale Price by Application (2021-2026)

3 GLOBAL BY COMPANY

3.1 Global Lecanemab Injection Breakdown Data by Company
  3.1.1 Global Lecanemab Injection Annual Sales by Company (2021-2026)
  3.1.2 Global Lecanemab Injection Sales Market Share by Company (2021-2026)
3.2 Global Lecanemab Injection Annual Revenue by Company (2021-2026)
  3.2.1 Global Lecanemab Injection Revenue by Company (2021-2026)
  3.2.2 Global Lecanemab Injection Revenue Market Share by Company (2021-2026)
3.3 Global Lecanemab Injection Sale Price by Company
3.4 Key Manufacturers Lecanemab Injection Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Lecanemab Injection Product Location Distribution
  3.4.2 Players Lecanemab Injection Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR LECANEMAB INJECTION BY GEOGRAPHIC REGION

4.1 World Historic Lecanemab Injection Market Size by Geographic Region (2021-2026)
  4.1.1 Global Lecanemab Injection Annual Sales by Geographic Region (2021-2026)
  4.1.2 Global Lecanemab Injection Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Lecanemab Injection Market Size by Country/Region (2021-2026)
  4.2.1 Global Lecanemab Injection Annual Sales by Country/Region (2021-2026)
  4.2.2 Global Lecanemab Injection Annual Revenue by Country/Region (2021-2026)
4.3 Americas Lecanemab Injection Sales Growth
4.4 APAC Lecanemab Injection Sales Growth
4.5 Europe Lecanemab Injection Sales Growth
4.6 Middle East & Africa Lecanemab Injection Sales Growth

5 AMERICAS

5.1 Americas Lecanemab Injection Sales by Country
  5.1.1 Americas Lecanemab Injection Sales by Country (2021-2026)
  5.1.2 Americas Lecanemab Injection Revenue by Country (2021-2026)
5.2 Americas Lecanemab Injection Sales by Type (2021-2026)
5.3 Americas Lecanemab Injection Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Lecanemab Injection Sales by Region
  6.1.1 APAC Lecanemab Injection Sales by Region (2021-2026)
  6.1.2 APAC Lecanemab Injection Revenue by Region (2021-2026)
6.2 APAC Lecanemab Injection Sales by Type (2021-2026)
6.3 APAC Lecanemab Injection Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Lecanemab Injection by Country
  7.1.1 Europe Lecanemab Injection Sales by Country (2021-2026)
  7.1.2 Europe Lecanemab Injection Revenue by Country (2021-2026)
7.2 Europe Lecanemab Injection Sales by Type (2021-2026)
7.3 Europe Lecanemab Injection Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Lecanemab Injection by Country
  8.1.1 Middle East & Africa Lecanemab Injection Sales by Country (2021-2026)
  8.1.2 Middle East & Africa Lecanemab Injection Revenue by Country (2021-2026)
8.2 Middle East & Africa Lecanemab Injection Sales by Type (2021-2026)
8.3 Middle East & Africa Lecanemab Injection Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Lecanemab Injection
10.3 Manufacturing Process Analysis of Lecanemab Injection
10.4 Industry Chain Structure of Lecanemab Injection

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Lecanemab Injection Distributors
11.3 Lecanemab Injection Customer

12 WORLD FORECAST REVIEW FOR LECANEMAB INJECTION BY GEOGRAPHIC REGION

12.1 Global Lecanemab Injection Market Size Forecast by Region
  12.1.1 Global Lecanemab Injection Forecast by Region (2027-2032)
  12.1.2 Global Lecanemab Injection Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Lecanemab Injection Forecast by Type (2027-2032)
12.7 Global Lecanemab Injection Forecast by Application (2027-2032)

13 KEY PLAYERS ANALYSIS

13.1 Eisai
  13.1.1 Eisai Company Information
  13.1.2 Eisai Lecanemab Injection Product Portfolios and Specifications
  13.1.3 Eisai Lecanemab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  13.1.4 Eisai Main Business Overview
  13.1.5 Eisai Latest Developments
13.2 Biogen
  13.2.1 Biogen Company Information
  13.2.2 Biogen Lecanemab Injection Product Portfolios and Specifications
  13.2.3 Biogen Lecanemab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  13.2.4 Biogen Main Business Overview
  13.2.5 Biogen Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Lecanemab Injection Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Lecanemab Injection Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 200mg per Vial
Table 4. Major Players of 500mg per Vial
Table 5. Global Lecanemab Injection Sales by Type (2021-2026) & (K Units)
Table 6. Global Lecanemab Injection Sales Market Share by Type (2021-2026)
Table 7. Global Lecanemab Injection Revenue by Type (2021-2026) & ($ million)
Table 8. Global Lecanemab Injection Revenue Market Share by Type (2021-2026)
Table 9. Global Lecanemab Injection Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Lecanemab Injection Sale by Application (2021-2026) & (K Units)
Table 11. Global Lecanemab Injection Sale Market Share by Application (2021-2026)
Table 12. Global Lecanemab Injection Revenue by Application (2021-2026) & ($ million)
Table 13. Global Lecanemab Injection Revenue Market Share by Application (2021-2026)
Table 14. Global Lecanemab Injection Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Lecanemab Injection Sales by Company (2021-2026) & (K Units)
Table 16. Global Lecanemab Injection Sales Market Share by Company (2021-2026)
Table 17. Global Lecanemab Injection Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Lecanemab Injection Revenue Market Share by Company (2021-2026)
Table 19. Global Lecanemab Injection Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Lecanemab Injection Producing Area Distribution and Sales Area
Table 21. Players Lecanemab Injection Products Offered
Table 22. Lecanemab Injection Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Lecanemab Injection Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Lecanemab Injection Sales Market Share Geographic Region (2021-2026)
Table 27. Global Lecanemab Injection Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Lecanemab Injection Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Lecanemab Injection Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Lecanemab Injection Sales Market Share by Country/Region (2021-2026)
Table 31. Global Lecanemab Injection Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Lecanemab Injection Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Lecanemab Injection Sales by Country (2021-2026) & (K Units)
Table 34. Americas Lecanemab Injection Sales Market Share by Country (2021-2026)
Table 35. Americas Lecanemab Injection Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Lecanemab Injection Sales by Type (2021-2026) & (K Units)
Table 37. Americas Lecanemab Injection Sales by Application (2021-2026) & (K Units)
Table 38. APAC Lecanemab Injection Sales by Region (2021-2026) & (K Units)
Table 39. APAC Lecanemab Injection Sales Market Share by Region (2021-2026)
Table 40. APAC Lecanemab Injection Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Lecanemab Injection Sales by Type (2021-2026) & (K Units)
Table 42. APAC Lecanemab Injection Sales by Application (2021-2026) & (K Units)
Table 43. Europe Lecanemab Injection Sales by Country (2021-2026) & (K Units)
Table 44. Europe Lecanemab Injection Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Lecanemab Injection Sales by Type (2021-2026) & (K Units)
Table 46. Europe Lecanemab Injection Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Lecanemab Injection Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Lecanemab Injection Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Lecanemab Injection Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Lecanemab Injection Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Lecanemab Injection
Table 52. Key Market Challenges & Risks of Lecanemab Injection
Table 53. Key Industry Trends of Lecanemab Injection
Table 54. Lecanemab Injection Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Lecanemab Injection Distributors List
Table 57. Lecanemab Injection Customer List
Table 58. Global Lecanemab Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Lecanemab Injection Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Lecanemab Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Lecanemab Injection Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Lecanemab Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Lecanemab Injection Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Lecanemab Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Lecanemab Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Lecanemab Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Lecanemab Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Lecanemab Injection Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Lecanemab Injection Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Lecanemab Injection Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Lecanemab Injection Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Eisai Basic Information, Lecanemab Injection Manufacturing Base, Sales Area and Its Competitors
Table 73. Eisai Lecanemab Injection Product Portfolios and Specifications
Table 74. Eisai Lecanemab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Eisai Main Business
Table 76. Eisai Latest Developments
Table 77. Biogen Basic Information, Lecanemab Injection Manufacturing Base, Sales Area and Its Competitors
Table 78. Biogen Lecanemab Injection Product Portfolios and Specifications
Table 79. Biogen Lecanemab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Biogen Main Business
Table 81. Biogen Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Lecanemab Injection
Figure 2. Lecanemab Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Lecanemab Injection Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Lecanemab Injection Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Lecanemab Injection Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Lecanemab Injection Sales Market Share by Country/Region (2025)
Figure 10. Lecanemab Injection Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 200mg per Vial
Figure 12. Product Picture of 500mg per Vial
Figure 13. Global Lecanemab Injection Sales Market Share by Type in 2026
Figure 14. Global Lecanemab Injection Revenue Market Share by Type (2021-2026)
Figure 15. Lecanemab Injection Consumed in Mild Dementia
Figure 16. Global Lecanemab Injection Market: Mild Dementia (2021-2026) & (K Units)
Figure 17. Lecanemab Injection Consumed in Mild Cognitive Impairment
Figure 18. Global Lecanemab Injection Market: Mild Cognitive Impairment (2021-2026) & (K Units)
Figure 19. Lecanemab Injection Consumed in Other
Figure 20. Global Lecanemab Injection Market: Other (2021-2026) & (K Units)
Figure 21. Global Lecanemab Injection Sale Market Share by Application (2025)
Figure 22. Global Lecanemab Injection Revenue Market Share by Application in 2026
Figure 23. Lecanemab Injection Sales by Company in 2026 (K Units)
Figure 24. Global Lecanemab Injection Sales Market Share by Company in 2026
Figure 25. Lecanemab Injection Revenue by Company in 2026 ($ millions)
Figure 26. Global Lecanemab Injection Revenue Market Share by Company in 2026
Figure 27. Global Lecanemab Injection Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Lecanemab Injection Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Lecanemab Injection Sales 2021-2026 (K Units)
Figure 30. Americas Lecanemab Injection Revenue 2021-2026 ($ millions)
Figure 31. APAC Lecanemab Injection Sales 2021-2026 (K Units)
Figure 32. APAC Lecanemab Injection Revenue 2021-2026 ($ millions)
Figure 33. Europe Lecanemab Injection Sales 2021-2026 (K Units)
Figure 34. Europe Lecanemab Injection Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Lecanemab Injection Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Lecanemab Injection Revenue 2021-2026 ($ millions)
Figure 37. Americas Lecanemab Injection Sales Market Share by Country in 2026
Figure 38. Americas Lecanemab Injection Revenue Market Share by Country (2021-2026)
Figure 39. Americas Lecanemab Injection Sales Market Share by Type (2021-2026)
Figure 40. Americas Lecanemab Injection Sales Market Share by Application (2021-2026)
Figure 41. United States Lecanemab Injection Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Lecanemab Injection Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Lecanemab Injection Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Lecanemab Injection Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Lecanemab Injection Sales Market Share by Region in 2026
Figure 46. APAC Lecanemab Injection Revenue Market Share by Region (2021-2026)
Figure 47. APAC Lecanemab Injection Sales Market Share by Type (2021-2026)
Figure 48. APAC Lecanemab Injection Sales Market Share by Application (2021-2026)
Figure 49. China Lecanemab Injection Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Lecanemab Injection Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Lecanemab Injection Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Lecanemab Injection Revenue Growth 2021-2026 ($ millions)
Figure 53. India Lecanemab Injection Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Lecanemab Injection Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Lecanemab Injection Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Lecanemab Injection Sales Market Share by Country in 2026
Figure 57. Europe Lecanemab Injection Revenue Market Share by Country (2021-2026)
Figure 58. Europe Lecanemab Injection Sales Market Share by Type (2021-2026)
Figure 59. Europe Lecanemab Injection Sales Market Share by Application (2021-2026)
Figure 60. Germany Lecanemab Injection Revenue Growth 2021-2026 ($ millions)
Figure 61. France Lecanemab Injection Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Lecanemab Injection Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Lecanemab Injection Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Lecanemab Injection Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Lecanemab Injection Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Lecanemab Injection Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Lecanemab Injection Sales Market Share by Application (2021-2026)
Figure 68. Egypt Lecanemab Injection Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Lecanemab Injection Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Lecanemab Injection Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Lecanemab Injection Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Lecanemab Injection Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Lecanemab Injection in 2026
Figure 74. Manufacturing Process Analysis of Lecanemab Injection
Figure 75. Industry Chain Structure of Lecanemab Injection
Figure 76. Channels of Distribution
Figure 77. Global Lecanemab Injection Sales Market Forecast by Region (2027-2032)
Figure 78. Global Lecanemab Injection Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Lecanemab Injection Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Lecanemab Injection Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Lecanemab Injection Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Lecanemab Injection Revenue Market Share Forecast by Application (2027-2032)